Glycemic control and Oxidative stress with Glimepiride or Nateglinide alone in type 2 OHA naive diabetic patients.
Not Applicable
- Conditions
- type 2 diabetes
- Registration Number
- JPRN-UMIN000000725
- Lead Sponsor
- Tokyo Medical University The 3rd Department of Internal Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 140
Inclusion Criteria
Not provided
Exclusion Criteria
Exclusion Criteria: 1) Patients except type 2 diabetic patients. 2) Patients taking Probucol, vitamin E and/or vitamin C. 3) Alcoholic,or heavy drinker. 4) Patients operated malignant and gastro extraction. 5) Patients with serious complications of DM. Nephropathy:*. Retinopathy:** 6) Drug anaphylaxis patient. 7) Pregnant or patients who plan to carry, or currently breast-feeding woman. 8) Patients who were judged inappropriate to participate in this study by the doctor of study director or cooperative *Proteinuria >= 1g/day ** Stage of preproliferative and proliferative retinopaty by Davis classification
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method